MAPK8IP1 Antibody (YA8784)

Cat. No.: HY-P89100: Data Sheet User Guide for Antibodies
FAQs
Technical Support

MAPK8IP1 Antibody (YA8784) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAPK8IP1.

For research use only. We do not sell to patients.

Size		Stock
50 μL		Get quote
100 μL		Get quote

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

MAPK8IP1 Antibody (YA8784) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MAPK8IP1.

Host

Mouse

Clonality

Monoclonal

Molecular Weight

Predicted band size: 77.3 kDa

Species Reactivity

Human, Mouse, Rat

SwissProt ID

Q9UQF2

Immunogen

Full length human recombinant protein of human MAPK8IP1 produced in HEK293T cell.

Application &
Dilution Ratio

Application	Dilution Ratio
IHC-P IHC-P: Immunohistochemistry-Paraffin	1:150-500

Sensitivity	Endogenous	Purity	Affinity purified
Conjugation	Non-conjugated	Modification	Unmodified
Isotype	IgG1

Appearance

Liquid

Formulation

Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module. Required for JNK activation in response to excitotoxic stress. Cytoplasmic MAPK8IP1 causes inhibition of JNK-regulated activity by retaining JNK in the cytoplasm and inhibiting JNK phosphorylation of c-Jun. May also participate in ApoER2-specific reelin signaling. Directly, or indirectly, regulates GLUT2 gene expression and beta-cell function. Appears to have a role in cell signaling in mature and developing nerve terminals. May function as a regulator of vesicle transport, through interactions with the JNK-signaling components and motor proteins. Functions as an anti-apoptotic protein and whose level seems to influence the beta-cell death or survival response. Acts as a scaffold protein that coordinates with SH3RF1 in organizing different components of the JNK pathway, including RAC1 or RAC2, MAP3K11/MLK3 or MAP3K7/TAK1, MAP2K7/MKK7, MAPK8/JNK1 and/or MAPK9/JNK2 into a functional multiprotein complex to ensure the effective activation of the JNK signaling pathway. Regulates the activation of MAPK8/JNK1 and differentiation of CD8(+) T-cells

Subcellular Localization：Cytoplasm,Cytoplasm, perinuclear region,Nucleus,Endoplasmic reticulum membrane,Mitochondrion membrane

Expression：
Tissue_Specificity: Highly expressed in brain. Expressed in neurons, localizing to neurite tips in differentiating cells. Also expressed in the pancreas, testis and prostate. Low levels in heart, ovary and small intestine. Decreased levels in pancreatic beta cells sensitize cells to IL-1-beta-induced apoptosis

Isoforms & Post-Translational Modification：Q9UQF2: 711 amino acids, molecular weight 77524 Da.

Subunit：Forms homo- or heterooligomeric complexes

Synonyms

IB1; JIP-1; JIP1; PRKM8IP

Documentation

User Guide for Antibodies (1077 KB)